Fennec Pharmaceuticals(DE:RV41)
€12.20+0.10 (+0.83%)
DE:RV41
Fennec Pharmaceuticals earnings date
€12.20
At close:+0.10 (+0.83%)
Fennec Pharmaceuticals (RV41) Q4 2023 Earnings Report
0 Followers
DE:RV41 Q4 2023 EPS Results
- Actual EPS
- -EUR 0.09
- Consensus EPS
- -EUR 0.02
- Beat/Miss
- Missed by -EUR 0.07
- One Year Ago EPS
- -EUR 0.24
DE:RV41 Q4 2023 Revenue Results
- Actual Revenue
- EUR 8.85M
- Expected Revenue
- EUR 7.88M
- Beat/Miss
- Beat by +EUR 973.22K
- YoY Revenue Growth
- +534.20%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 03/21/2024
- Time
- Before Open
- Conference Call
- Thursday, March 21, 2024
DE:RV41 Upcoming Earnings
Fennec Pharmaceuticals's next earnings date is estimated for March 30, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
DE:RV41 Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:RV41 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 30, 2027 | 2026 (Q4) | 0.15- | -0.15 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | 0.090.11 | -0.02 | 700.00% (+0.13) | |
| Aug 11, 2026 | 2026 (Q2) | 0.020.05 | -0.1 | 145.45% (+0.15) | |
| May 14, 2026 | 2026 (Q1) | -0.040.01 | -0.04 | 125.00% (+0.05) | |
| Mar 24, 2026 | 2025 (Q4) | 0.04-0.15 | -0.05 | -183.33% (-0.10) | |
| Nov 13, 2025 | 2025 (Q3) | -0.02-0.02 | -0.19 | 90.48% (+0.17) | |
| Aug 14, 2025 | 2025 (Q2) | -0.03-0.10 | -0.18 | 45.00% (+0.08) | |
| May 13, 2025 | 2025 (Q1) | -0.08-0.04 | 0.37 | -109.76% (-0.41) | |
| Mar 10, 2025 | 2024 (Q4) | -0.12-0.05 | -0.09 | 40.00% (+0.04) | |
| Nov 07, 2024 | 2024 (Q3) | -0.08-0.19 | -0.06 | -200.00% (-0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

